vs

Side-by-side financial comparison of CoastalSouth Bancshares, Inc. (COSO) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

CoastalSouth Bancshares, Inc. is the larger business by last-quarter revenue ($21.3M vs $14.7M, roughly 1.4× IRIDEX CORP).

CoastalSouth Bancshares, Inc. is a U.S.-based regional bank holding company. It provides a full range of personal and commercial banking services including deposit accounts, consumer loans, mortgages, commercial financing and wealth management solutions for retail customers and small-to-medium enterprises across the U.S. Gulf Coast region.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

COSO vs IRIX — Head-to-Head

Bigger by revenue
COSO
COSO
1.4× larger
COSO
$21.3M
$14.7M
IRIX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
COSO
COSO
IRIX
IRIX
Revenue
$21.3M
$14.7M
Net Profit
$6.7M
Gross Margin
37.2%
Operating Margin
41.2%
Net Margin
31.7%
Revenue YoY
-69.7%
Net Profit YoY
EPS (diluted)
$0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COSO
COSO
IRIX
IRIX
Q4 25
$14.7M
Q3 25
$21.3M
$12.5M
Q2 25
$19.9M
$13.6M
Q1 25
$11.9M
Q4 24
$12.7M
Q3 24
$11.6M
Q2 24
$12.6M
Q1 24
$11.8M
Net Profit
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
$6.7M
$-1.6M
Q2 25
$6.0M
$-994.0K
Q1 25
$-1.7M
Q4 24
$-834.0K
Q3 24
$-1.9M
Q2 24
$-2.7M
Q1 24
$-3.5M
Gross Margin
COSO
COSO
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
41.2%
-11.3%
Q2 25
35.4%
-6.9%
Q1 25
-1.7%
Q4 24
-3.9%
Q3 24
-16.1%
Q2 24
-20.9%
Q1 24
-28.0%
Net Margin
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
31.7%
-12.6%
Q2 25
30.0%
-7.3%
Q1 25
-14.2%
Q4 24
-6.6%
Q3 24
-16.7%
Q2 24
-21.2%
Q1 24
-29.5%
EPS (diluted)
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
$0.54
$-0.09
Q2 25
$0.57
$-0.06
Q1 25
$-0.10
Q4 24
$-0.05
Q3 24
$-0.12
Q2 24
$-0.16
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COSO
COSO
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$250.4M
Total Assets
$2.3B
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COSO
COSO
IRIX
IRIX
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
$250.4M
$4.7M
Q2 25
$209.4M
$6.1M
Q1 25
$852.0K
Q4 24
$2.1M
Q3 24
$2.6M
Q2 24
$4.2M
Q1 24
$6.5M
Total Assets
COSO
COSO
IRIX
IRIX
Q4 25
$29.2M
Q3 25
$2.3B
$28.4M
Q2 25
$2.2B
$31.6M
Q1 25
$34.2M
Q4 24
$29.1M
Q3 24
$30.2M
Q2 24
$31.2M
Q1 24
$34.1M
Debt / Equity
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COSO
COSO
IRIX
IRIX
Operating Cash FlowLast quarter
$-5.5M
Free Cash FlowOCF − Capex
$-5.9M
FCF MarginFCF / Revenue
-27.7%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
-0.82×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
$-5.5M
$-1.2M
Q2 25
$-16.8M
$-397.0K
Q1 25
$-1.1M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
$-1.3M
Q1 24
$-1.6M
Free Cash Flow
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
$-5.9M
$-1.2M
Q2 25
$-17.9M
$-410.0K
Q1 25
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-1.7M
FCF Margin
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
-27.7%
-9.4%
Q2 25
-90.3%
-3.0%
Q1 25
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-14.0%
Capex Intensity
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
1.9%
0.1%
Q2 25
5.5%
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
COSO
COSO
IRIX
IRIX
Q4 25
Q3 25
-0.82×
Q2 25
-2.82×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons